Link Between Chronic Kidney Disease & Heart Failure Identified

Cardiac dysfunction and cardiovascular events are prevalent among chronic kidney disease patients without overt obstructive coronary artery disease, but the mechanisms remain poorly understood. Now, a new study finds the link between kidney disease to progressive heart disease. The findings of the study are published in the journal Circulation. This offers a potential treatment target, which could have wide benefits because 14 percent of the U.S. adult population has chronic kidney disease. The research is published in the journal Circulation, with Bajaa UAB assistant professor in the Division of Cardiovascular Disease, Department of Medicine and Department of Radiology as first author.

"I am now collaborating with other UAB researchers to figure out how we can target therapeutics to help these patients," Bajaj said.

The pathological change identified is coronary microvascular dysfunction, or CMD, say Bajaj and research colleagues at Harvard Medical School. CMD is decreased blood flow in the small blood vessels inside the heart muscle that provide oxygen and fuel to feed the pumping heart.

In healthy hearts, visualized postmortem, these blood vessels look like a tight filigree network that fills the heart muscle tissue. A diseased postmortem heart has lost much of this network. In living patients, however, those small blood vessels inside the heart muscle cannot be visualized; blood flow scans of living patients visualize only the larger, exterior coronary arteries. So Bajaj and colleagues needed an indirect way to gauge CMD.

That measure is coronary flow reserve, or CFR, which Bajaj and colleagues measured via positron emission tomography. CFR is the maximum increase in blood flow through the coronary arteries above the normal resting volume. Bajaj, a cardiologist who trained at UAB, did his advanced imaging fellowship at Brigham and Women’s Hospital in Boston, before returning to UAB in 2018.

In a longitudinal study of 352 patients with chronic kidney disease, all with healthy heart function as measured by ejection fraction and none with signs of overt coronary artery disease, the researchers measured CFR and also measured signs of subclinical heart dysfunction via deformation analysis with echocardiograms. The patients have then followed a median of 4.4 years for major adverse cardiac events. A total of 108 patients had such major events, including death and hospitalization for non-fatal heart attack or heart failure.

Advertisement

The researchers found that CMD was a significant predictor of abnormal mechanics of the left ventricle the heart’s major pumping chamber and a significant predictor of clinical risk of adverse cardiovascular outcomes.

A statistical model called mediation analysis examined the relationship between impaired kidney function and heart disease. It showed that CMD accounted for 19 to 24 percent of left ventricular diastolic dysfunction, 19 to 42 percent of left ventricular systolic dysfunction and 32 percent of major adverse cardiovascular events.

Advertisement

These significant associations "provide important new evidence that the development of severe microvascular dysfunction likely signals the transition from physiological to pathological left ventricle remodeling that increases the risk of heart failure and death in patients with chronic kidney disease," the study said. "To the best of our knowledge, our study is the first and largest to comprehensively explore these associations and to suggest a possible pathway to the development of uremic cardiomyopathy in individuals without overt ischemic heart disease."

Source-Eurekalert